Andrew T. Ferenbach
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Cell wall target fragment discovery using a low-cost, minimal fragment library.
Journal: FEBS letters
Published: July 30, 2025
Multi-domain O-GlcNAcase structures reveal allosteric regulatory mechanisms.
Journal: Nature communications
Published: March 10, 2025
Zscan4 as a Candidate Conveyor of Early Developmental Defects in O-GlcNAc Transferase Intellectual Disability.
Journal: Molecular & cellular proteomics : MCP
Published: February 20, 2025
Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants.
Journal: Stem cell reports
Published: June 15, 2024
Neuroectoderm phenotypes in a human stem cell model of O-GlcNAc transferase associated with intellectual disability.
Journal: Molecular genetics and metabolism
Published: February 07, 2024
Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability.
Journal: Disease models & mechanisms
Published: December 21, 2023
Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation.
Journal: Glycobiology
Published: June 19, 2023
O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis.
Journal: Nature communications
Published: April 18, 2022
Genetic validation of Aspergillus fumigatus phosphoglucomutase as a viable therapeutic target in invasive aspergillosis.
Journal: The Journal of biological chemistry
Published: January 12, 2022
Last Updated: 09/26/2026